Lv4
416 积分 2025-08-18 加入
Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma in 2025
2天前
已完结
Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti‐cancer therapy
26天前
已完结
Preclinical mouse models of hepatocellular carcinoma: An overview and update
26天前
已完结
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification
26天前
已完结
Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial
1个月前
已完结
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma
1个月前
已完结
CCNE1 Amplification and PKMYT1 Inhibition Are Synthetic Lethal
1个月前
已关闭
Differential Assembly of Mouse and Human Tumor Microenvironments
1个月前
已完结
Risk factors for cholangiocarcinoma
1个月前
已完结
Perturbation of calreticulin potentiates CD8+ T cell–mediated antitumor immunity
2个月前
已完结
皖公网安备34019202002308
